Rybelsus Alternatives: Every Option Compared on Results
6 other FDA-approved GLP-1 medicines share a use with Rybelsus: Ozempic, Wegovy, Mounjaro, Trulicity, Victoza and Byetta. Wegovy is a tablet, if you want to avoid needles. The lowest self-pay start among them is $149 per month for Wegovy.
- Same-use GLP-1 options
- 6
- Needle-free options
- Wegovy
- Lowest self-pay alternative
- $149 per month, Wegovy
Rybelsus in brief
With a half-life of about 1 week, half is gone once 7 d pass, and about 3% remains once five half-lives (35 d) have passed
In PIONEER 1, people with type 2 diabetes lost 3.7 kg over 26 weeks, while the placebo group lost 1.4 kg.
Monthly prices in US dollars include list prices and self-pay offers, each taken from the maker's price page.
Sources: FDA label (DailyMed), healthsystemtracker.org, Novo Nordisk pricing, Novo Nordisk.
Prescription alternatives to Rybelsus
| Medicine | Ingredient | How it is taken | Shared use | Trial weight loss | Self-pay from |
|---|---|---|---|---|---|
 Ozempic | semaglutide | weekly injection | heart risk and type 2 diabetes | Not listed | $199 per month |
 Wegovy | semaglutide | weekly injection or daily tablet | heart risk | 14.9% | $149 per month |
 Mounjaro | tirzepatide | weekly injection | heart risk and type 2 diabetes | Not listed | Not listed |
 Trulicity | dulaglutide | weekly injection | heart risk and type 2 diabetes | Not listed | Not listed |
 Victoza | liraglutide | daily injection | heart risk and type 2 diabetes | Not listed | Not listed |
| Byetta | exenatide | twice-daily injection | type 2 diabetes | Not listed | Not listed |
Sources: TrumpRx, FDA label (DailyMed).